3-deoxy mycaminosyl tylonolide derivatives
    3.
    发明公开
    3-deoxy mycaminosyl tylonolide derivatives 失效
    3-脱氧碳霉糖基太乐内酯衍生物

    公开(公告)号:EP0347158A2

    公开(公告)日:1989-12-20

    申请号:EP89305945.1

    申请日:1989-06-13

    IPC分类号: C07H17/08 A61K31/70

    CPC分类号: C07H17/08

    摘要: 3-Deoxy mycaminosyl tylonolide derivatives represented by the following general formula and salts thereof:
    wherein X represents an oxygen atom or =N-OR⁴ (wherein R⁴ represents hydrogen or lower alkyl); R¹ represents a hydrogen atom, an acyl group or an alkylsilyl group; R² represents a hydrogen atom or an acyl group; and R³ represents a hydrogen atom or a hydroxyl group. The compounds of formula (I) have excellent antibacterial activity.

    摘要翻译: 由下列通式表示的3-脱氧碳霉糖基太乐内酯衍生物及其盐:其中X代表氧原子或= N-OR 4(其中R 4代表氢或低级烷基); R 1代表氢原子,酰基或烷基甲硅烷基; R 2代表氢原子或酰基; R 3代表氢原子或羟基。 式(I)化合物具有优异的抗菌活性。

    1-N-(4-Amino-3-fluoro-2-hydroxybutyryl)-kanamycins
    9.
    发明公开
    1-N-(4-Amino-3-fluoro-2-hydroxybutyryl)-kanamycins 失效
    1-N-(4-氨基-3-氟-2-羟基丁基)卡那霉素。

    公开(公告)号:EP0285526A2

    公开(公告)日:1988-10-05

    申请号:EP88420066.8

    申请日:1988-02-24

    IPC分类号: C07H15/234 A61K31/70

    CPC分类号: C07H15/234

    摘要: As new compound are now provided ten compounds, namely 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-kanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybuty- ryl}-2',3'-dideoxykanamycin A; 1-N-{(2R,3R)-4-amino-fluoro-2-hydorxybutyryl}-2',3'-dideoxy-2'-fluorokanamycin A; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin A; 1-N-((2R,3R)-4-amino-fluoro-2-hydrox- ybutyryl}-kanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hy- droxybutyryl}-3'-deoxykanamycin B; 1-N-((2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3',4'-dideoxykanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin B; 1-N-{(2R,3R)-4-amino-3-fluoro-2-hydrox- ybutyryl}-5,3'-dideoxy-5-fluorokanamycin B; and 1-N{(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3',4'-tride- oxy-5-fluorokanamycin B, which are all useful as antibacterial agent in the therapeutic treatment of bacterial infections.

    摘要翻译: 现在提供了新的化合物十个化合物,即1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} - 卡那霉素A; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -2',3'-二脱氧卡那霉素A; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -2',3'-二脱氧-2'-感染甲卡霉素A; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -5-脱氧-5-氟霉素A; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} - 卡那霉素B; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -3'-脱氧卡那霉素B; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -3',4'-二脱氧卡那霉素B; 1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -5-脱氧-5-氟霉素B; 在B中的1-N - {(2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -5,3'-二脱氧-5-氟代烟酰胺; 和1-N((2R,3R)-4-氨基-3-氟-2-羟基丁酰基} -5,3',4'-三脱氧-5-氟卡那霉素B,它们都可用作治疗剂中的抗菌剂 治疗细菌感染。